However, only 3.7 percent of the 456 patients with chilblains were positive for SARS-CoV-2
WEDNESDAY, June 23, 2021 (HealthDay News) — There is a weak correlation for COVID-19 cases with incidence of chilblains, according to a study published online June 23 in JAMA Dermatology.
Patrick E. McCleskey, M.D., from The Permanente Medical Group Northern California in Oakland, and colleagues conducted a retrospective cohort study to examine the potential correlation between COVID-19 incidence and chilblains. Data were included for 780 patients with chilblains reported during the pandemic.
The researchers observed a correlation for COVID-19 incidence with chilblains incidence at 207 location-months (Spearman coefficient, 0.18). Of the 456 patients with chilblains tested during the pandemic, only 3.7 percent were positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and only 2.0 percent were positive for SARS-CoV-2 within six weeks of chilblains diagnosis. Test results from 1.0 percent of patients were positive for immunoglobulin G antibodies to SARS-CoV-2. COVID-19, but not chilblains, disproportionately affected Latinx patients.
“Although this study found a weak geographic and temporal correlation of COVID-19 cases with chilblains cases, these findings may have resulted from behavioral changes,” the authors write. “Very few cases of chilblains were positive for COVID-19.”
Freshwater Swimming Tied to Stomach Bugs, Skin Conditions 
Considerable Global Disparities Found in Access to Dermatological Care 
Extreme Heat Linked to 33 Clinically Reportable Diagnoses 
Psoriasis Linked to Impairment of Some Sleep Domains 
Burden of Myocardial Dysfunction Elevated for Individuals With Psoriasis 
Dose Reduction of Biologics Effective, Safe for Psoriasis 
